Home/EpiBiologics/Eric Humke, M.D., Ph.D.
EH

Eric Humke, M.D., Ph.D.

Chief Medical Officer

EpiBiologics

EpiBiologics Pipeline

DrugIndicationPhase
c-MET Degrading Bispecific AntibodyOncology (likely various solid tumors)Preclinical